Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Pathology”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02239900
What this trial is testing

Ipilimumab and Stereotactic Body Radiation Therapy (SBRT) in Advanced Solid Tumors

Who this might be right for
Liver CancerLung Cancer
M.D. Anderson Cancer Center 143
Testing effectiveness (Phase 2)Study completedNCT05637541
What this trial is testing

Evaluation of The Safety, Efficacy and Pharmacokinetic Characteristics of GST-HG141 Tablets

Who this might be right for
Chronic Hepatitis b
Fujian Akeylink Biotechnology Co., Ltd. 90
Not applicableStudy completedNCT06358001
What this trial is testing

EchoTip AcuCore Post-Market Clinical Study

Who this might be right for
AdenocarcinomaNeuroendocrine TumorsHepatocellular Carcinoma+5 more
Cook Research Incorporated 183
Post-approval studies (Phase 4)Study completedNCT01205165
What this trial is testing

An Open Label, Multi Centre Phase IV Study of Adefovir Dipivoxil in Korean Patients With Chronic Hepatitis B (CHB)

Who this might be right for
Hepatitis B, Chronic
GlaxoSmithKline 104
Post-approval studies (Phase 4)UnknownNCT02308319
What this trial is testing

Prompt Or Watchful Monitoring for Hepatitis B Virus Related Hepatocellular Carcinoma Without Elevated viRal Load

Who this might be right for
Carcinoma, Hepatocellular
Samsung Medical Center 124
Not applicableEnrolling By InvitationNCT07001865
What this trial is testing

Metabolically Healthy Obesity Increases the Risks of MASLD and Hyperuricemia

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseMetabolically Healthy ObesityHyperuricemia
Ningbo No. 1 Hospital 17,040
Not applicableLooking for participantsNCT06687122
What this trial is testing

Egg Intake, Metabolic Outcomes and Choline Levels

Who this might be right for
Obesity and Obesity-related Medical Conditions
University of Guelph 20
Not applicableStudy completedNCT01974830
What this trial is testing

AL1TER™: Alpha-1 Therapy, Evaluation, and Research Patient Registry

Who this might be right for
Alpha-1 Anti-trypsin Deficiency
Coram Clinical Trials 120
Testing effectiveness (Phase 2)Looking for participantsNCT06015022
What this trial is testing

EGCG for Hepatocellular Carcinoma Chemoprevention

Who this might be right for
Cirrhosis, Liver
University of Texas Southwestern Medical Center 60
Not applicableEnded earlyNCT03694431
What this trial is testing

Comparative Trial of Home-Based Palliative Care

Who this might be right for
CancerChronic Obstructive Pulmonary DiseaseHeart Failure+4 more
Kaiser Permanente 3,999
Testing effectiveness (Phase 2)Study completedNCT04321395
What this trial is testing

Vigabatrin and Insulin Sensitivity

Who this might be right for
NAFLDObesity
Washington University School of Medicine 4
Not applicableStudy completedNCT06319222
What this trial is testing

Implementation of a Digital Clinic for Alcohol-associated Liver Disease and Alcohol Use Disorder (DALC)

Who this might be right for
Alcohol Use DisorderLiver Diseases
Mayo Clinic 145
Not applicableStudy completedNCT06573229
What this trial is testing

LIver FRAilty Management IN Cirrhosis (LIFRAMIN)

Who this might be right for
SarcopeniaCirrhosis, LiverMalnutrition; Protein
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 30
Testing effectiveness (Phase 2)Study completedNCT00035945
What this trial is testing

ISIS 14803-CS2, Treatment With ISIS 14803, Administered IV in Patients With Chronic Hepatitis C Virus Infections

Who this might be right for
Hepatitis C, Chronic
Ionis Pharmaceuticals, Inc.
Early research (Phase 1)Study completedNCT05331872
What this trial is testing

Umbilical Cord-derived Mesenchymal Stem Cell Infusion in the Management of Adult Liver Cirrhosis

Who this might be right for
Liver Cirrhosis
Vinmec Research Institute of Stem Cell and Gene Technology 20
Large-scale testing (Phase 3)Study completedNCT02105467
What this trial is testing

Study of Efficacy and Safety of Grazoprevir (MK-5172)/Elbasvir (MK-8742) Combination Regimen for Treatment-Naïve Participants With Chronic Hepatitis C Virus Genotypes 1, 4, and 6 (MK-5172-060)

Who this might be right for
Chronic Hepatitis C Virus
Merck Sharp & Dohme LLC 421
Not applicableStudy completedNCT05281211
What this trial is testing

Nutrition and Exercise Prehabilitation to Reduce Morbidity Following Major Liver Surgery in Sarcopenic Patients

Who this might be right for
Liver CancerSurgerySarcopenia
San Camillo Hospital, Rome 70
Early research (Phase 1)Study completedNCT06525311
What this trial is testing

Evaluate the Pharmacokinetics and Safety of K-808 (Pemafibrate) in Subjects With Primary Biliary Cholangitis With Compensated Cirrhosis and Without Cirrhosis.

Who this might be right for
Primary Biliary CholangitisCompensated Cirrhosis
Kowa Research Institute, Inc. 17
Post-approval studies (Phase 4)Study completedNCT00467545
What this trial is testing

An Extension to Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Novartis Pharmaceuticals 44
Large-scale testing (Phase 3)Ended earlyNCT06488911
What this trial is testing

To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate

Who this might be right for
Primary Biliary Cholangitis
Intercept Pharmaceuticals 62
Next Page